Press Release No. 027/KFCP-DIR/PR/X/15
Jakarta, 18 October 2015 – PT Kalbe Farma Tbk (Kalbe) through Kalbe Ethical Customer Care (KECC) and Indonesia Cancer Care Community (ICCC) today commemorates the Breast Cancer Awareness Month. The event is held at Kelapa Gading Jogging Park, North Jakarta, taking the theme "Dance to Pink." Around 300 breast cancer patients, survivors, and observers will be present in the event. The event is attended by Dr. Carmen Jahja, MD. Sports Medicine, Deputy Chief of Indonesian Cancer Foundation of DKI Jakarta, and Dr. Walta Gautama SpB(K)Onk, a cancer/tumor surgeon from RS Mitra Keluarga Kelapa Gading.
“Kalbe will always present its commitment for public health in general, and cancer patients in particular. We will always encourage breast cancer patients to not lose hope and remain productive,” said Ridwan Ong, Marketing Director of PT Kalbe Farma Tbk. "Many women are still blissfully unaware on cancer prevention options because they felt that they are healthy. Whereas in reality, this deadly disease showed no symptoms at all in the early stages.” he said.
Breast Cancer Awareness Month is commemorated in the world on every month of October, and is dedicated to help increase attention and support of the awareness, early detection, medication, and palliative care of breast cancer. In the talk show presented by Dr. Walta Gautama St, SpB (K)Onc., he will discuss early detection, prevention, and care of breast cancer.
Beside the talk show, there will also be power walks activity around the event location, sharing sessions from breast cancer survivors, health checks for blood glucose and pressure, and charity presentation for Indonesian Cancer Foundation of DKI Jakarta.
At present day, breast cancer is a type of cancer that is severely frightening for Indonesian women. Breast cancer has the tendency to affect women over the age of 50. There are 8 to 10 cases of breast cancer occurring for women at this age. There are several factors that trigger breast cancer on women. Aside of genetic and environmental factors, lifestyle is also one of the leading cause of breast cancer. There is no adequate knowledge on the actual cause of breast cancer; therefore early detection should be one of the methods of control of breast cancer. When breast cancer is detected early and diagnostic and medication is adequately available, there is the opportunity for breast cancer o be healed.
The threat of cancer in Indonesia is also increasing with the change of lifestyle of the population. According to World Cancer Prevention Organization and World Health Organization, it is predicted to be an increase of cancer by 300 percent by year 2030, and the majority of the case will happen in developing countries, including Indonesia. According to the Department of Health, at present, there is 1 cancer patient in 1,000 in Indonesia and it is estimated that there will be 200,000 new cancer patients every year.
Kalbe Ethical Customer Care (KECC) at a glance
Kalbe Ethical Customer Care or KECC is a forum dedicated to providing information and education to the public about overall health.
KECC works to increase the awareness and concern of the public for their own health. In addition, the public is also encouraged to always identify the prevention and medication of diseases, especially chronic or degenerative diseases. In every activity, KECC also perform a variety of checks for the participants such as: bone density check, blood sugar, blood pressure, etc.
Kalbe at a glance
PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle their reliable and diverse brand portfolio, prescription drugs (Cefspan, Brainact, Broadced, etc); over-the-counter drugs (Woods, Promag, Mixagrip, Komix, Fatigon, etc); nutrition (ChilKid, Prenagen, Diabetasol, etc); and distribution business units. Kalbe currently has 9 production facilities with international standard, and employs more than 17,000 employees throughout Indonesia. From 1991, Kalbe is listed at Indonesia Stock Exchange (IDX:KLBF).